Two-year OS of cohorts treated with first-line ABVD by country GDP per capita. All first-line studies that used ABVD as primary treatment and reported OS (y-axis) plotted by country GDP per capita (x-axis).¹¹ Each study is represented by a dot with varying size (number of patients in the study) and color (World Health Organization region).